A Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesopha... von Chao, Y., Maglakelidze, M., Bulat, L.V., Yau, T., Tanasanvimon, S., Charoentum, C., Arpornwirat, W., Maneechavakajorn, J., Dechaphunkul, A., Ungtrakul, T., Yen, C.-J., Bai, L.-Y., Chou, W.-C., Weidermann, U., Garner-Spitzer, E., Ede, N., Chong, L., Good, A.

Volltext

1212PComprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immun... von Wiedermann, U, Garner-Spitzer, E, Chao, Y, Bulat, I, Dechaphunkul, A, Arpornwirat, W, Charoentum, C, Yen, C J, Yau, T, Maglakelidzde, M, Tanasanvimon, S, Maneechavakajorn, J, Sookprasert, A, Bai, L-Y, Chou, W-C, Ungtrakul, T, Zielinski, C C, Chong, L, Ede, N, Good, A

Volltext

1212P - Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, im... von Wiedermann, U., Garner-Spitzer, E., Chao, Y., Bulat, I., Dechaphunkul, A., Arpornwirat, W., Charoentum, C., Yen, C.J., Yau, T., Maglakelidzde, M., Tanasanvimon, S., Maneechavakajorn, J., Sookprasert, A., Bai, L.-Y., Chou, W.-C., Ungtrakul, T., Zielinski, C.C., Chong, L., Ede, N., Good, A.

Volltext

Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immunogeni... von Wiedermann, U., Garner-Spitzer, E., Chao, Y., Bulat, I., Dechaphunkul, A., Arpornwirat, W., Charoentum, C., Yen, C.J., Yau, T., Maglakelidzde, M., Tanasanvimon, S., Maneechavakajorn, J., Sookprasert, A., Bai, L.-Y., Chou, W.-C., Ungtrakul, T., Zielinski, C.C., Chong, L., Ede, N., Good, A.

Volltext

414TiP An open-label phase 2a study of combination dabrafenib (D) and trametinib (T) in Asian patients (pts) with advanced BRAF V600-mutant acral lentiginous melanoma (ALM) or cuta... von Guo, J., Chang, W.-C., Dechaphunkul, A., Fan, Y., Kim, T.M., Lin, C.-C., Maneechavakajorn, J., Shin, S.J., Song, X., Cheng, S.-T., Thongprasert, S., Wong, B.S., Wu, D., Zhang, X., Bettinger, S., Zhang, P., Mookerjee, B.

Volltext

414TiP An open-label phase 2a study of combination dabrafenib (D) and trametinib (T) in Asian patients (pts) with advanced BRAF V600–mutant acral lentiginous melanoma (ALM) or cuta... von Guo, J., Chang, W-C., Dechaphunkul, A., Fan, Y., Kim, T.M., Lin, C-C., Maneechavakajorn, J., Shin, S.J., Song, X., Cheng, S-T., Thongprasert, S., Wong, C.S., Wu, D., Zhang, X., Bettinger, S., Zhang, P., Mookerjee, B.

Volltext

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer von Laohavinij, S, Maoleekoonpairoj, S, Cheirsilpa, A, Maneechavakajorn, J, Sirachainant, E, Arpornvivat, W, Jaisathaporn, K, Ratanatharathorn, V

Volltext

Quality of life, Functional Assessment of Cancer Therapy-General von Ratanatharathorn, V, Sirilerttrakul, S, Jirajarus, M, Silpakit, C, Maneechavakajorn, J, Sailamai, P, Sirisinha, T

Volltext

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine von Goh, G, Schmid, R, Guiver, K, Arpornwirat, W, Chitapanarux, I, Ganju, V, Im, SA, Kim, SB, Dechaphunkul, A, Maneechavakajorn, J, Spector, N, Yau, T, Afrit, M, Ahmed, SB, Johnston, SR, Gibson, N, Uttenreuther-Fischer, M, Herrero, J, Swanton, C

Volltext bestellen

Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001 von Wiedermann, Ursula, Garner-Spitzer, Erika, Chao, Yee, Maglakelidze, Marina, Bulat, Iurie, Dechaphunkul, Arunee, Arpornwirat, Wichit, Charoentum, Chaiyut, Yen, Chia-Jui, Yau, Thomas Cheung, Tanasanvimon, Suebpong, Maneechavakajorn, Jedzada, Sookprasert, Aumkhae, Bai, Li-Yuan, Chou, Wen-Chi, Ungtrakul, Teerapat, Drinic, Mirjana, Tobias, Joshua, Zielinski, Christoph C, Chong, Leslie, Ede, Nicholas J, Marino, Mark T, Good, Anthony J

Volltext

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's p... von Gligorov, J, Ataseven, B, Verrill, M, De Laurentiis, M, Jung, K.H, Azim, H.A, Al-Sakaff, N, Lauer, S, Shing, M, Pivot, X

Volltext

A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesopha... von Chao, Yee, Yau, Thomas, Maglakelidze, Marina, Bulat, Iurie, Tanasanvimon, Suebpong, Charoentum, Chaiyut, Arpornwirat, Wichit, Maneechavakajorn, Jedzada, Dechaphunkul, Arunee, Ungtrakul, Teerapat, Yen, Chia-Jui, Bai, Li-Yuan, Chou, Wen-Chi, Wiedermann, Ursula, Good, Anthony J, Ede, Nick, Chong, Leslie Mi Ok

Volltext

Abstract CT059: A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, im... von Wiedermann, Ursula, Garner-Spitzer, Erika, Chao, Yee, Bulat, Iurie, Dechaphunkul, Arunee, Arpornwirat, Wichit, Charoentum, Chaiyut, Yen, Chia-Jui, Yau, Thomas Cheung, Maglakelidze, Marina, Tanasanvimon, Suebpong, Maneechavakajorn, Jedzada, Sookprasert, Aumkhae, Bai, Li-Yuan, Chou, Wen-Chi, Ungtrakul, Teerapat, Zielinski, Christoph C., Chong, Leslie, Ede, Nick, Good, Anthony J

Volltext

A phase Ib/II open label study of IMU-131 HER2/Neu peptide vaccine plus cisplatin and either 5-fluorouracil or capecitabine chemotherapy in patients with HER2/Neu overexpressing me... von Wiedermann, Ursula, Good, Anthony J, Garner-Spitzer, Erika, Chao, Yee, Bulat, Iurie, Dechaphunkul, Arunee, Arpornwirat, Wichit, Charoentum, Chaiyut, Yen, Chia-Jui, Yau, Thomas Cheung, Maglakelidze, Marina, Tanasanvimon, Suebpong, Maneechavakajorn, Jedzada, Sookprasert, Aumkhae, Bai, Li-Yuan, Chou, Wen-Chi, Ungtrakul, Teerapat, Chong, Leslie, Ede, Nick

Volltext